Clinical Trials Browser

Phase 4 × Sofosbuvir × Clear all

NCT05717400 2024-12-31

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

Phase 4 Terminated

2 enrolled 8 charts

Gastrointestinal

Liver Neoplasms

NCT02717949 2019-01-08

Optimal

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Phase 4 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic